Search
Now showing items 1-10 of 21
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice
(Rockville: American Society for Pharmacology and Experimental Therapeutics (ASPET), 2007)
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
(Molecular Cancer Therapeutics, 2008)
Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes
(Journal of Autoimmunity, 2004)
5-Aza-2 '-deoxycytidine and paclitaxel inhibit inducible nitric oxide synthase activation in fibrosarcoma cells
(European Journal of Pharmacology, 2004)
Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells
(Cellular and Molecular Life Sciences, 2005)
Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation
(Immunology of Diabetes: Autoimmune Mechanisms and the Prevention and Cure of Type 1 Diabetes, 2002)